Loading clinical trials...

UNKNOWNPhase 1/2NCT02279147

Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.

RATIONALE:Anticholinesterase drugs and cholinergic M receptor antagonist are applied to patients who have obstructive jaundice after operation. PURPOSE:This clinical trial was designed to lower the i...

Lead sponsor: Wanqing Gu•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Wanqing GU, MD

CONTACT

+86-10-66938334 [email protected]

Yurong LIANG, MD

CONTACT

+86-10-66938334 [email protected]

Related studies

RECRUITINGPhase 4

Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

NCT06122987 · Septic Shock, Shock, and more

RECRUITINGPhase 4

Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC

NCT05172739 · Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, and more

Active Not Recruiting

Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB

NCT07583290 · Cardiac Surgical Procedures, Cardiopulmonary Bypass, and more

Active Not RecruitingNA

A RCT of Low MBO Drainage Strategies

NCT06196164 · Jaundice, Obstructive, Cholangiopancreatography, Endoscopic Retrograde, and more

Active Not RecruitingNA

Initial Feasibility Study of the CycloPE® Device

NCT06970899 · Sepsis, Infection, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 30, 2014Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE1/PHASE2

Enrollment100

Start dateAug 2014

Last updatedOct 30, 2014

Condition

Systemic Inflammatory Response Syndrome Jaundice, Obstructive

Locations shown

CHN Chinese PLA General Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions